Literature DB >> 20209379

Cardiac gene expression and systemic cytokine profile are complementary in a murine model of post-ischemic heart failure.

S Lachtermacher1, B L B Esporcatte, F Montalvão, P C Costa, D C Rodrigues, L Belem, A Rabischoffisky, H C C Faria Neto, R Vasconcellos, S Iacobas, D A Iacobas, H F R Dohmann, D C Spray, R C S Goldenberg, A C Campos-de-Carvalho.   

Abstract

After myocardial infarction (MI), activation of the immune system and inflammatory mechanisms, among others, can lead to ventricular remodeling and heart failure (HF). The interaction between these systemic alterations and corresponding changes in the heart has not been extensively examined in the setting of chronic ischemia. The main purpose of this study was to investigate alterations in cardiac gene and systemic cytokine profile in mice with post-ischemic HF. Plasma was tested for IgM and IgG anti-heart reactive repertoire and inflammatory cytokines. Heart samples were assayed for gene expression by analyzing hybridization to AECOM 32k mouse microarrays. Ischemic HF significantly increased the levels of total serum IgM (by 5.2-fold) and total IgG (by 3.6-fold) associated with a relatively high content of anti-heart specificity. A comparable increase was observed in the levels of circulating pro-inflammatory cytokines such as IL-1beta (3.8X) and TNF-alpha (6.0X). IFN-gamma was also increased by 3.1-fold in the MI group. However, IL-4 and IL-10 were not significantly different between the MI and sham-operated groups. Chemokines such as MCP-1 and IL-8 were 1.4- and 13-fold increased, respectively, in the plasma of infarcted mice. We identified 2079 well annotated unigenes that were significantly regulated by post-ischemic HF. Complement activation and immune response were among the most up-regulated processes. Interestingly, 21 of the 101 quantified unigenes involved in the inflammatory response were significantly up-regulated and none were down-regulated. These data indicate that post-ischemic heart remodeling is accompanied by immune-mediated mechanisms that act both systemically and locally.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20209379      PMCID: PMC3032498          DOI: 10.1590/s0100-879x2010007500014

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  37 in total

Review 1.  Left ventricular remodeling after myocardial infarction: pathophysiology and therapy.

Authors:  M G Sutton; N Sharpe
Journal:  Circulation       Date:  2000-06-27       Impact factor: 29.690

2.  GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways.

Authors:  Kam D Dahlquist; Nathan Salomonis; Karen Vranizan; Steven C Lawlor; Bruce R Conklin
Journal:  Nat Genet       Date:  2002-05       Impact factor: 38.330

3.  Impact of viral and bacterial infectious burden on long-term prognosis in patients with coronary artery disease.

Authors:  H J Rupprecht; S Blankenberg; C Bickel; G Rippin; G Hafner; W Prellwitz; W Schlumberger; J Meyer
Journal:  Circulation       Date:  2001-07-03       Impact factor: 29.690

Review 4.  Chronic heart failure and the immune system.

Authors:  Daniela Mari; Federica Di Berardino; Massimo Cugno
Journal:  Clin Rev Allergy Immunol       Date:  2002-12       Impact factor: 8.667

Review 5.  The inflammatory response in myocardial infarction.

Authors:  Nikolaos G Frangogiannis; C Wayne Smith; Mark L Entman
Journal:  Cardiovasc Res       Date:  2002-01       Impact factor: 10.787

6.  Heart failure and greater infarct expansion in middle-aged mice: a relevant model for postinfarction failure.

Authors:  Kenneth E Gould; George E Taffet; Lloyd H Michael; Robert M Christie; Debra L Konkol; Jennifer S Pocius; Justin P Zachariah; Damian F Chaupin; Sherita L Daniel; George E Sandusky; Craig J Hartley; Mark L Entman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-02       Impact factor: 4.733

7.  Cytotoxic T lymphocytes are activated following myocardial infarction and can recognize and kill healthy myocytes in vitro.

Authors:  N Varda-Bloom; J Leor; D G Ohad; Y Hasin; M Amar; R Fixler; A Battler; M Eldar; D Hasin
Journal:  J Mol Cell Cardiol       Date:  2000-12       Impact factor: 5.000

8.  Gene expression profile in mouse myocardium after ischemia.

Authors:  D Lyn; X Liu; N A Bennett; N L Emmett
Journal:  Physiol Genomics       Date:  2000-04-27       Impact factor: 3.107

9.  Regeneration of natural antibody repertoire after massive ablation of lymphoid system: robust selection mechanisms preserve antigen binding specificities.

Authors:  Alberto Nobrega; Beatriz Stransky; Nathalie Nicolas; Antonio Coutinho
Journal:  J Immunol       Date:  2002-09-15       Impact factor: 5.422

10.  MAPPFinder: using Gene Ontology and GenMAPP to create a global gene-expression profile from microarray data.

Authors:  Scott W Doniger; Nathan Salomonis; Kam D Dahlquist; Karen Vranizan; Steven C Lawlor; Bruce R Conklin
Journal:  Genome Biol       Date:  2003-01-06       Impact factor: 13.583

View more
  14 in total

1.  Functional and transcriptomic recovery of infarcted mouse myocardium treated with bone marrow mononuclear cells.

Authors:  Stephan Lachtermacher; Bruno L B Esporcatte; Fábio da Silva de Azevedo Fortes; Nazareth Novaes Rocha; Fabrício Montalvão; Patricia C Costa; Luciano Belem; Arnaldo Rabischoffisky; Hugo C C Faria Neto; Rita Vasconcellos; Dumitru A Iacobas; Sanda Iacobas; David C Spray; Neil M Thomas; Regina C S Goldenberg; Antonio C Campos de Carvalho
Journal:  Stem Cell Rev Rep       Date:  2012-03       Impact factor: 5.739

Review 2.  Role of cytokines and inflammation in heart function during health and disease.

Authors:  Monika Bartekova; Jana Radosinska; Marek Jelemensky; Naranjan S Dhalla
Journal:  Heart Fail Rev       Date:  2018-09       Impact factor: 4.214

Review 3.  The role of B-cells in heart failure.

Authors:  Andrea M Cordero-Reyes; Keith A Youker; Guillermo Torre-Amione
Journal:  Methodist Debakey Cardiovasc J       Date:  2013 Jan-Mar

Review 4.  Epigenomic and transcriptomic approaches in the post-genomic era: path to novel targets for diagnosis and therapy of the ischaemic heart? Position Paper of the European Society of Cardiology Working Group on Cellular Biology of the Heart.

Authors:  Cinzia Perrino; Albert-Laszló Barabási; Gianluigi Condorelli; Sean Michael Davidson; Leon De Windt; Stefanie Dimmeler; Felix Benedikt Engel; Derek John Hausenloy; Joseph Addison Hill; Linda Wilhelmina Van Laake; Sandrine Lecour; Jonathan Leor; Rosalinda Madonna; Manuel Mayr; Fabrice Prunier; Joost Petrus Geradus Sluijter; Rainer Schulz; Thomas Thum; Kirsti Ytrehus; Péter Ferdinandy
Journal:  Cardiovasc Res       Date:  2017-06-01       Impact factor: 10.787

Review 5.  Lymphocytic subsets play distinct roles in heart diseases.

Authors:  Jing Wang; Yi Duan; Joost Pg Sluijter; Junjie Xiao
Journal:  Theranostics       Date:  2019-05-31       Impact factor: 11.556

6.  Cardiac-specific ablation of glutaredoxin 3 leads to cardiac hypertrophy and heart failure.

Authors:  Jimmonique Donelson; Qiongling Wang; Tanner O Monroe; Xiqian Jiang; Jianjie Zhou; Han Yu; Qianxing Mo; Qin Sun; Juan C Marini; Xinquan Wang; Paul A Nakata; Kendal D Hirschi; Jin Wang; George G Rodney; Xander H T Wehrens; Ninghui Cheng
Journal:  Physiol Rep       Date:  2019-04

Review 7.  Role of Inflammatory Cell Subtypes in Heart Failure.

Authors:  Derek Strassheim; Edward C Dempsey; Evgenia Gerasimovskaya; Kurt Stenmark; Vijaya Karoor
Journal:  J Immunol Res       Date:  2019-09-02       Impact factor: 4.818

8.  Analysis of region specific gene expression patterns in the heart and systemic responses after experimental myocardial ischemia.

Authors:  Matthias Zimmermann; Lucian Beer; Robert Ullrich; Dominika Lukovic; Elisabeth Simader; Denise Traxler; Tanja Wagner; Lucas Nemec; Lukas Altenburger; Andreas Zuckermann; Mariann Gyöngyösi; Hendrik Jan Ankersmit; Michael Mildner
Journal:  Oncotarget       Date:  2017-05-17

Review 9.  Cardiac Remodeling: Endothelial Cells Have More to Say Than Just NO.

Authors:  Vincent F M Segers; Dirk L Brutsaert; Gilles W De Keulenaer
Journal:  Front Physiol       Date:  2018-04-11       Impact factor: 4.566

10.  NULP1 Alleviates Cardiac Hypertrophy by Suppressing NFAT3 Transcriptional Activity.

Authors:  Xin Zhang; Fang Lei; Xiao-Ming Wang; Ke-Qiong Deng; Yan-Xiao Ji; Yan Zhang; Hongliang Li; Xiao-Dong Zhang; Zhibing Lu; Peng Zhang
Journal:  J Am Heart Assoc       Date:  2020-08-04       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.